Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CEBP Focus Archive
    • Meeting Abstracts
    • Progress and Priorities
    • Collections
      • COVID-19 & Cancer Resource Center
      • Disparities Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Informing Public Health Policy
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Epidemiology, Biomarkers & Prevention
Cancer Epidemiology, Biomarkers & Prevention
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CEBP Focus Archive
    • Meeting Abstracts
    • Progress and Priorities
    • Collections
      • COVID-19 & Cancer Resource Center
      • Disparities Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Informing Public Health Policy
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Research Articles

Urinary Thymidine Dimer as a Marker of Total Body Burden of UV-Inflicted DNA Damage in Humans

Natalia Kotova, Kari Hemminki and Dan Segerbäck
Natalia Kotova
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kari Hemminki
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dan Segerbäck
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1158/1055-9965.EPI-05-0164 Published December 2005
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Figure 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1.

    32P-HPLC chromatogram of thymine dimer (T = T). A, 10 fmol of T = T standard after photoreversion to parental dinucleotide followed by 32P-postlabeling (32pTpT). B, 10 fmol of T = T postlabeled directly without photoreversion. C, urine sample collected before solarium tanning. D. Urine sample collected 1 day after tanning (peak contains 4.3 fmol of 32pTpT).

  • Figure 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 2.

    Kinetic of urinary thymine dimer (T = T) excretion after UV irradiation as mean values (± SD) for 10 persons during 20 to 30 minutes of solarium use. Time 0 represents the T = T level in samples taken just before the tanning session. The data for each day are expressed as a percentage of the total amount of T = T and compared statistically (t test) with day 3 (*, P < 0.05; **, P < 0.01; ***, P < 0.001).

  • Figure 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 3.

    Cumulative thymine dimer (T = T) levels after UV irradiation for the six volunteers who were followed up to 11 days. Time 0 represents the T = T level in samples taken just before the tanning session.

Tables

  • Figures
  • Table 1.

    Amounts of urinary thymine dimer (T = T) after UV irradiation in a solarium and the rates for its excretion

    VolunteerSexDose (J/m2)Amount of T = T*, (nmol)Amount of T = T (pmol per m2 body surface area per J/m2)50% excretion time† (hours)
    1F3833.65.869
    2F2563.39.062
    3F1241.99.370
    4F2563.47.465
    5F3832.43.670
    6F3832.94.655
    7M3835.57.275
    8M1922.96.671
    9F3832.03.564
    10M3831.62.076
    • ↵* Total amount of T = T for 5 days assuming an average excretion of 160 μmol creatinine per kg body weight per day for women and 200 μmol for men (10).

    • ↵† The 50% excretion time was calculated from the excretion rate during the first 5 days following UV irradiation.

  • Table 2.

    Relative amounts of urinary thymine dimer excreted for 5 days following different UV sessions in a solarium

    VolunteerPercentage of session A
    30-minute exposure (A)50% of the time (B)50% of the body (C)Repeated ARepeated B
    1100263229
    2100402958
    310097
    4100465346
    510057103
    61005069122
    7100533351
    9100586197
    1010031
    Average ± SD10047 ± 1144 ± 17105 ± 1246 ± 12
    • NOTE: The data for session A were taken from the fourth column of Table 1 (volunteer 8 participated only in session A and was therefore not included). For session B, the exposure time was 50% of that in session A. For session C, the upper part of the solarium was covered resulting in 50% of the body being exposed. Sessions A and B were repeated once.

PreviousNext
Back to top
Cancer Epidemiology Biomarkers & Prevention: 14 (12)
December 2005
Volume 14, Issue 12
  • Table of Contents

Sign up for alerts

View this article with LENS

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Epidemiology, Biomarkers & Prevention article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Urinary Thymidine Dimer as a Marker of Total Body Burden of UV-Inflicted DNA Damage in Humans
(Your Name) has forwarded a page to you from Cancer Epidemiology, Biomarkers & Prevention
(Your Name) thought you would be interested in this article in Cancer Epidemiology, Biomarkers & Prevention.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Urinary Thymidine Dimer as a Marker of Total Body Burden of UV-Inflicted DNA Damage in Humans
Natalia Kotova, Kari Hemminki and Dan Segerbäck
Cancer Epidemiol Biomarkers Prev December 1 2005 (14) (12) 2868-2872; DOI: 10.1158/1055-9965.EPI-05-0164

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Urinary Thymidine Dimer as a Marker of Total Body Burden of UV-Inflicted DNA Damage in Humans
Natalia Kotova, Kari Hemminki and Dan Segerbäck
Cancer Epidemiol Biomarkers Prev December 1 2005 (14) (12) 2868-2872; DOI: 10.1158/1055-9965.EPI-05-0164
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • Estimated Effects of Multi-Cancer Screening
  • Gene–Environment Interaction Portfolio Analysis
  • Risk Prediction for Renal Cell Carcinoma
Show more Research Articles
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook   Twitter   LinkedIn   YouTube   RSS

Articles

  • Online First
  • Current Issue
  • Past Issues

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Cancer Epidemiology, Biomarkers & Prevention

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Cancer Epidemiology, Biomarkers & Prevention
eISSN: 1538-7755
ISSN: 1055-9965

Advertisement